Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Christopher Toepfer

Oxford BHF CRE Basic Science Intermediate Transition Fellow

  • Start Date: 01/10/2019
  • End Date: 31/12/2021
  • BHF CRE Mentors: Prof Hugh Watkins & Prof Charles Redwood

Where am I now?

I have been awarded a Sir Henry Dale Fellowship, by the Royal Society and the Wellcome Trust, which will start in October 2021.  This 5 year fellowship will support the further development of my research group in the Division of Cardiovascular Medicine at the University of Oxford.

Research project title: Defining Key Mechanisms of HCM and DCM Variant Pathogenicity in a Human Cellular Model of Disease 

Research summary:

We investigate the role of mutations in key contractile proteins in hypertrophic cardiomyopathy (HCM). The laboratory focuses on CRISPR/Cas-9 engineering of human induced pluripotent stem cells. These cells can be differentiated into cardiomyocytes, which are used to model human heart disease in a dish.

Christopher Toepfer Project Human Cardiomyocyte.png

Photo: Human cardiomyocyte derived from a human stem cell that has the contractile unit of the cell, the sarcomere, labelled with GFP.

Biography:

I have always been fascinated about the way the heart functions, and the processes that govern how the muscle of the heart is able to efficiently pump blood around the body. I spent my doctoral years dissecting key mechanisms of heart muscle regulation. I then moved to Boston to study how these mechanisms can go wrong in disease. I have since returned to Oxford to begin my own research group to identify these key mechanisms of disease and understand how we can design novel therapies for patients with these cardiac conditions.

Undergraduate Degrees/Training:

2019-2021 British Heart Foundation Centre of Research Excellence Intermediate Fellow. Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford. Fellowship title: Defining key mechanisms of HCM and DCM variant pathogenicity in a human cellular model of disease.

2018-2019 Eugene Braunwald Named Fellowship of Brigham and Women’s Hospital, Harvard Medical School, Boston. Department of Genetics and Brigham and Women’s Hospital, Harvard Medical School, Boston. https://cvls.bwh.harvard.edu/division-honors/

2017-2021 Sir Henry Wellcome Fellowship, Wellcome Trust. Department of Genetics, Harvard Medical School & Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford

2015-2017 Post-doctoral Fellow Harvard Medical School. Department of Genetics, Harvard Medical School, Boston.

2010-2015 Wellcome Trust/NIH 4 year PhD studentship. PhD funded by the Wellcome Trust and National Institutes of Health investigating the role of myosin light chain phosphorylation on the stress response of the heart. In Professor Michael Ferenczi’s laboratory (NHLI, Imperial College London) and Dr James Seller’s laboratory (NHLBI, NIH). Thesis title ‘The role of myosin regulatory light chain phosphorylation in cardiac health and disease’

2007-2010 BSc Biomedical Science Imperial College London.